RAPT Therapeutics Slips 9% After Pricing Public Offering

On:

Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.

The company today priced its public offering of 4,054,055 shares at $18.50 per share.

Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.

RAPT has traded in the range of $9.85- $40.74 in the last 1 year.

Source: Read Full Article

Lates News:
  1. Dollar Tree Falls On Lower Quarterly Profit, Outlook Shy Of Estimates
  2. Bitcoin, ETH, XRP, ADA Get Stuck In Tight Ranges As Investors Attune To The Jackson Hole Symposium
  3. Extreme Networks Climbs 6%; Launches Outdoor Wi-Fi 6E Access Point
  4. Cryptos Flat As Global Markets Turn Risk Averse
  5. $ETH: CME Group Shows Impeccable Timing With Launch of Its Options on Ether Futures